These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36146497)

  • 1. Preventing the Next Pandemic: Is Live Vaccine Efficacious against Monkeypox, or Is There a Need for Killed Virus and mRNA Vaccines?
    Abdelaal A; Reda A; Lashin BI; Katamesh BE; Brakat AM; Al-Manaseer BM; Kaur S; Asija A; Patel NK; Basnyat S; Rabaan AA; Alhumaid S; Albayat H; Aljeldah M; Shammari BRA; Al-Najjar AH; Al-Jassem AK; AlShurbaji ST; Alshahrani FS; Alynbiawi A; Alfaraj ZH; Alfaraj DH; Aldawood AH; Sedhai YR; Mumbo V; Rodriguez-Morales AJ; Sah R
    Vaccines (Basel); 2022 Aug; 10(9):. PubMed ID: 36146497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    Rao AK; Petersen BW; Whitehill F; Razeq JH; Isaacs SN; Merchlinsky MJ; Campos-Outcalt D; Morgan RL; Damon I; Sánchez PJ; Bell BP
    MMWR Morb Mortal Wkly Rep; 2022 Jun; 71(22):734-742. PubMed ID: 35653347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monkeypox in human pregnancy: an overview.
    Daneji SM; Aminu A; Borodo AM; Dayyab FM
    AJOG Glob Rep; 2022 Nov; 2(4):100130. PubMed ID: 36405871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview on mRNA-based vaccines to prevent monkeypox infection.
    Natami M; Gorgzadeh A; Gholipour A; Fatemi SN; Firouzeh N; Zokaei M; Mohammed Ali SH; Kheradjoo H; Sedighi S; Gholizadeh O; Kalavi S
    J Nanobiotechnology; 2024 Mar; 22(1):86. PubMed ID: 38429829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Global Monkeypox (Mpox) Outbreak: A Comprehensive Review.
    Srivastava S; Kumar S; Jain S; Mohanty A; Thapa N; Poudel P; Bhusal K; Al-Qaim ZH; Barboza JJ; Padhi BK; Sah R
    Vaccines (Basel); 2023 Jun; 11(6):. PubMed ID: 37376482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments.
    Soheili M; Nasseri S; Afraie M; Khateri S; Moradi Y; Mahdavi Mortazavi SM; Gilzad-Kohan H
    J Pharm Pharm Sci; 2022; 25():297-322. PubMed ID: 36130588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of the modified vaccinia Ankara virus vaccine and the replication-competent vaccine ACAM2000 in monkeypox prevention.
    Kandeel M; Morsy MA; Abd El-Lateef HM; Marzok M; El-Beltagi HS; Al Khodair KM; Albokhadaim I; Venugopala KN
    Int Immunopharmacol; 2023 Jun; 119():110206. PubMed ID: 37087871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poxvirus Vaccines: Past, Present, and Future.
    Jhancy M
    Adv Exp Med Biol; 2024; 1451():273-287. PubMed ID: 38801584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo.
    Priyamvada L; Carson WC; Ortega E; Navarra T; Tran S; Smith TG; Pukuta E; Muyamuna E; Kabamba J; Nguete BU; Likafi T; Kokola G; Lushima RS; Tamfum JM; Okitolonda EW; Kaba DK; Monroe BP; McCollum AM; Petersen BW; Satheshkumar PS; Townsend MB
    Vaccine; 2022 Nov; 40(50):7321-7327. PubMed ID: 36344361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of monkeypox: a worldwide public health crisis.
    Begum JPS; Ngangom L; Semwal P; Painuli S; Sharma R; Gupta A
    Hum Cell; 2023 May; 36(3):877-893. PubMed ID: 36749539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monkeypox: considerations for the understanding and containment of the current outbreak in non-endemic countries.
    Quarleri J; Delpino MV; Galvan V
    Geroscience; 2022 Aug; 44(4):2095-2103. PubMed ID: 35726117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study.
    Cohn H; Bloom N; Cai GY; Clark JJ; Tarke A; Bermúdez-González MC; Altman DR; Lugo LA; Lobo FP; Marquez S; ; Chen JQ; Ren W; Qin L; Yates JL; Hunt DT; Lee WT; Crotty S; Krammer F; Grifoni A; Sette A; Simon V; Coelho CH
    Lancet Infect Dis; 2023 Nov; 23(11):1302-1312. PubMed ID: 37475115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress and prospects on vaccine development against monkeypox infection.
    Saadh MJ; Ghadimkhani T; Soltani N; Abbassioun A; Daniel Cosme Pecho R; Taha A; Jwad Kazem T; Yasamineh S; Gholizadeh O
    Microb Pathog; 2023 Jul; 180():106156. PubMed ID: 37201635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
    Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
    Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Biological, Pharmacological Characteristics, Indications, Contraindications and Adverse Effects of JYNNEOS and ACAM2000 Monkeypox Vaccines.
    Meo SA; Al-Masri AA; Klonoff DC; Alshahrani AN; Al-Khlaiwi T
    Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36423066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Monkeypox Virus: Current State of Knowledge and Implications for the Imminent Days.
    Ray SK; Mukherjee S
    Infect Disord Drug Targets; 2023; 23(6):e270423216283. PubMed ID: 37102477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Global Human Monkeypox Outbreak and Management: A Comprehensive Literature Review.
    Dighriri IM; Braiji SH; AlAnazi MM; Ayyashi MJ; Khubrani AA; Khormi YB; Shbeir LA; Alatif SI; Alfagih AE
    Cureus; 2022 Dec; 14(12):e32557. PubMed ID: 36654643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of monkeypox with vaccines: a rapid review.
    Poland GA; Kennedy RB; Tosh PK
    Lancet Infect Dis; 2022 Dec; 22(12):e349-e358. PubMed ID: 36116460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third-generation smallpox vaccines induce low-level cross-protecting neutralizing antibodies against Monkeypox virus in laboratory workers.
    Jandrasits D; Züst R; Siegrist D; Engler OB; Weber B; Schmidt KM; Jonsdottir HR
    Heliyon; 2024 May; 10(10):e31490. PubMed ID: 38826712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose - 32 U.S. Jurisdictions, July 31-September 3, 2022.
    Payne AB; Ray LC; Kugeler KJ; Fothergill A; White EB; Canning M; Farrar JL; Feldstein LR; Gundlapalli AV; Houck K; Kriss JL; Lewis NM; Sims E; Smith DK; Spicknall IH; Nakazawa Y; Damon IK; Cohn AC; Payne DC
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(40):1278-1282. PubMed ID: 36201401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.